Core Viewpoint - Dogwood Therapeutics, Inc. is set to report its third quarter 2025 financial results on November 6, 2025, before the market opens [1] Company Overview - Dogwood Therapeutics is a development-stage biotechnology company focused on creating new medicines for pain and neuropathic disorders [1]